Skip to content

Antidepressants Normalize the Default Mode Network in Patients With Dysthymia

Jonathan Posner, David J Hellerstein, Inbal Gat, Anna E. Mechling, Kristin Klahr, Zhishun Wang, Patrick J. Mcgrath, Jonathan W. Stewart, Bradley S. Peterson

JAMA Psychiatry February 6, 2013 DOI: 10.1001/jamapsychiatry.2013.455 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Placebo-controlled Double-blind Peer reviewed
Sample size 41
Population Subjects with dysthymic disorder and healthy control participants aged 18 to 53 years
Intervention Duloxetine
Duration 10-week intervention
Topics Default mode network Depression
Keywords Resting State FMRI Duloxetine Placebo Functional connectivity Magnetic resonance imaging Antidepressant Mood Hippocampus Pathology
Citations 275
Key findings At baseline, coherence of neural activity within the brain's default mode network was greater in persons with dysthymic disorder compared with healthy controls; after 10 weeks, treatment with duloxetine, but not placebo, normalized DMN connectivity.

Abstract

Importance: The default mode network (DMN) is a collection of brain regions that reliably deactivate during goal-directed behaviors and is more active during a baseline, or so-called resting, condition. Coherence of neural activity, or functional connectivity, within the brain's DMN is increased in major depressive disorder relative to healthy control (HC) subjects; however, whether similar abnormalities are present in persons with dysthymic disorder (DD) is unknown. Moreover, the effect of antidepressant medications on DMN connectivity in patients with DD is also unknown.

Objective: To use resting-state functional-connectivity magnetic resonance imaging (MRI) to study (1) the functional connectivity of the DMN in subjects with DD vs HC participants and (2) the effects of antidepressant therapy on DMN connectivity.

Design: After collecting baseline MRI scans from subjects with DD and HC participants, we enrolled the participants with DD into a 10-week prospective, double-blind, placebo-controlled trial of duloxetine and collected MRI scans again at the conclusion of the study. Enrollment occurred between 2007 and 2011.

Setting: University research institute.

Participants: Volunteer sample of 41 subjects with DD and 25 HC participants aged 18 to 53 years. Control subjects were group matched to patients with DD by age and sex. MAIN OUTCOME MEASURES: We used resting-state functional-connectivity MRI to measure the functional connectivity of the brain's DMN in persons with DD compared with HC subjects, and we examined the effects of treatment with duloxetine vs placebo on DMN connectivity.

Results: Of the 41 subjects with DD, 32 completed the clinical trial and MRI scans, along with the 25 HC participants. At baseline, we found that the coherence of neural activity within the brain's DMN was greater in persons with DD compared with HC subjects. Following a 10-week clinical trial, we found that treatment with duloxetine, but not placebo, normalized DMN connectivity.

Conclusions: AND RELEVANCE: The baseline imaging findings are consistent with those found in patients with major depressive disorder and suggest that increased connectivity within the DMN may be important in the pathophysiology of both acute and chronic manifestations of depressive illness. The normalization of DMN connectivity following antidepressant treatment suggests an important causal pathway through which antidepressants may reduce depression.

Comparable studies

Other randomized controlled trials on default mode network, most cited first.

Study Year Design Participants
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Healthy volunteers 2012 Within-subjects, placebo-controlled, task-free fMRI study n = 30
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers 2014 Placebo-controlled study
Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action Healthy subjects 2012 Randomized, placebo-controlled, double-blind, crossover rsfMRI challenge
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis Healthy volunteers 2012 Within-subject, placebo-controlled experimental study n = 15
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Participants following a single administration of psilocybin during a 5-day mindfulness... 2019 Randomized, double-blind, placebo-controlled study n = 38

Citations in the library

Explore topics